Furthermore, gastric mucosal MPO activity was significantly reduced in the pretreatment with AF at the doses of 50 and 250 mg/kg BW (P < 0.05), which was similar to pretreatment with famotidine (P < 0.01), as shown in Figure 5(c). Here, MPO is linked to atrial fibrillation.